Other
mNGS
mNGS is an intervention with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(1)
Other(3)
Detailed Status
unknown3
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
unknown360%
completed120%
not_yet_recruiting120%
Recent Activity
0 active trials
Showing 5 of 5
not_yet_recruiting
Anti-infection Therapy Based on mNGS Etiological Diagnosis and Infection After Liver Transplantation
NCT06212115
unknownnot_applicable
Economic Impact of mNGS on Diagnosis of Post-neurosurgical Central Nervous System Infection
NCT05887037
completed
Identification of Microbial DNA in Maternal Plasma After PPROM
NCT04318470
unknownnot_applicable
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
NCT04955756
unknownnot_applicable
mNGS Was Applied to the Study of Pathogen Identification, Precision Medication and Efficacy Evaluation of Infected Patients
NCT04310657
Clinical Trials (5)
Showing 5 of 5 trials
NCT06212115
Anti-infection Therapy Based on mNGS Etiological Diagnosis and Infection After Liver Transplantation
NCT05887037Not Applicable
Economic Impact of mNGS on Diagnosis of Post-neurosurgical Central Nervous System Infection
NCT04318470
Identification of Microbial DNA in Maternal Plasma After PPROM
NCT04955756Not Applicable
Early Identification and Severity Prediction of Acute Respiratory Infectious Disease
NCT04310657Not Applicable
mNGS Was Applied to the Study of Pathogen Identification, Precision Medication and Efficacy Evaluation of Infected Patients
All 5 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 5